Skip to content

BardPort, Groshong 0602820Recalls & reported problems

Bard Access Systems, Inc. · BardPort Titanium Implantable Port with Attachable 8F Groshong Single-Lumen Venous Catheter Basic Kit (Export Only) · Class 2 · Implant

All models of BardPort, Groshong (4)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741025709), received between May 7, 2022 and May 7, 2022 — classified as 1 injury.

The most frequently reported specific device problem is “Degraded” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Degraded1
  • Fluid/Blood Leak1
  • Fracture1
  • Peeled/Delaminated1

Patient problems

  • Extravasation1
  • Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 7, 2022Degraded; Fluid/Blood Leak; Fracture; Peeled/Delaminated; Degraded; Fluid/Blood Leak; Fracture; Peeled/Delaminated

    IT WAS REPORTED THAT APPROXIMATELY FOURTEEN YEARS AND TEN MONTHS POST PORT PLACEMENT PROCEDURE IN THE LEFT SUBCLAVIAN VEIN, THE CONTRAST MEDIUM ALLEGEDLY LEAKED. IT WAS FURTHER REPORTED THAT PATIENT EXPERIENCED PAIN AND EXTRAVASATION. THE CURRENT STATUS OF THE PATIENT IS UNKNOWN.

    Patient problems: Extravasation; Pain

    MAUDE report 14313478 ↗

Other PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices

All PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page